Genomics Services We Provide
Reproductive
Genetic insights that uncover the baby's risk of certain abnormalities to guide important health decisions during pregnancy.
Hereditary
From selected to comprehensive screening to find a diagnosis or understand whether the condition is inherited.
Oncology
Patient management through the understanding of genes responsible for cancer to find the
most effective and actionable treatments available.
Translational Research
Translational genomics with multi-omics research & clinical approach that will
eventually lead to new discoveries.
About LifeStrands Genomics
About LifeStrands Genomics
Headquartered in Singapore, we are part of Pathology Asia Holdings (PAH), which focuses on genomics and precision medicine test services. We believe everyone deserves access to better healthcare through the advancement of genomics. Our highly trained and dedicated team of experts are committed to providing more accurate, safer and reliable actionable genomics test services that allow clinicians to deliver more personalised, patient-centric recommendations based on individual genetic profiles.
Why Choose Us?
What We Believe In
Empowering
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Revolutionising
Lives can be transformed through the knowledge of genomics. We enable more informed decisions between clinicians and patients by providing safer, ethical and more accurate testing with more accessibility.
Tailoring
Gone were the days of a one-size-fits-all approach. We employ advanced genomics technologies and unique strategies to curate every clinical report based on the idea that each individual is unique.
Partnering with us
We believe in partnering to find the right answers in genomics.
Be part of our family
Have what it takes to make a difference? Begin your journey with us.
Latest LifeStrands News
Upcoming FPH ASM Event
We will be at the upcoming event on 19th August 2023 between 1030am and 5pm at Farrer Park Hospital.
Collaboration with Singapore PRECISE for Genetic Testing
We are delighted and honoured to be part of Singapore RIE 2025 HHP goals for CIPs in Phase II to